ACR Convergence 2020 Archives - Page 101 of 139

Abstract Number: 0851

Iberdomide Decreases B Cells and Plasmacytoid Dendritic Cells, Increases Regulatory T Cells and IL-2, and Has Enhanced Clinical Efficacy in Active Systemic Lupus Erythematosus Patients with High Aiolos or the IFN Gene Expression Signature
Abstract Number: 0806

Identification and Adjustment for Factors Associated with Clinical Response in Rheumatoid Arthritis Clinical Trials to Improve Comparisons of Treatment Efficacy
Abstract Number: 2043

Identification and Validation of Citrulline Specific TCRs in CD4+T Cells in Rheumatoid Arthritis
Abstract Number: 0039

Identification of a Regulatory Pathway Governing Expression of TRAF1 via a JIA-associated Non-coding Variant
Abstract Number: 2006

Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Abstract Number: 0069

Identification of CD13 as a Potential Cause for SARS-CoV-2-triggered Hyperinflammation and Thrombosis
Abstract Number: 1311

Identification of Clinical Phenotypes in Patients with Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis According to Peripheral Musculoskeletal Manifestations: A Cluster Analysis in the International ASAS-PerSpA Study
Abstract Number: 0666

Identification of Intracellular Vacuoles in Synovial Fluid with Calcium Pyrophosphate and Monosodium Urate Crystals
Abstract Number: 0179

Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine Learning
Abstract Number: 1338

Identification of Muscle Associated Key Genes to Support Axial Spondyloarthritis Diagnosis by Transcriptomic Approach, the MyoSpA Study
Abstract Number: 1848

Identification of Native and Citrullinated Autoantibodies to Psoriasis Related-antigen PsoP27 in Synovial Fluids of Patients with Psoriatic Arthritis
Abstract Number: 1849

Identification of New Associations Between Psoriatic Arthritis and the Gut Microbiota. the Mi-PART, a Phenomic Study
Abstract Number: 1865

Identification of Parameters Associated with a Diagnostic Delay in Axial Spondyloarthritis:Results from the European Map of Axial Spondyloarthritis (EMAS)
Abstract Number: 0785

Identification of Recruited CCR2+ Inflammatory Monocytes in a Mouse Model of RA-associated Lung Disease with Potential Role for resolvin-D1 in Reducing Monocyte Inflammatory Responses
Abstract Number: 0736

Identification of Salient Resilience Domains Among Adolescents with Chronic Musculoskeletal Pain and Their Parents
Abstract Number: 1948

Identification of Small Molecules with Efficacy as Steroid Sparing Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-like Synoviocytes
Abstract Number: 0658

Identification of Two Novel Dysfunctional Variants in a Physiologically Important Urate Transporter ABCG2 in Paediatric-onset Familial Hyperuricemia and Gout Patients in Three Generations
Abstract Number: 0866

Identifying an SLE Patient Cluster with Greater Treatment Effect: Immune Cell Deconvolution of Gene Expression in Two Atacicept Phase II Studies
Abstract Number: 1300

Identifying Cognitive Impairment in Patients with Systemic Lupus Erythematosus Using Hidden Markov Models: A Bayesian Approach
Abstract Number: 0175

Identifying Immuno-phenotypes in Juvenile Localized Scleroderma with RNA Sequencing
Abstract Number: 0371

Identifying Inadequate Response Among Ankylosing Spondylitis Patients Prescribed Biologics in a Real-world Commercially Insured Adult Population in the United States
Abstract Number: 0823

Identifying Physician-Perceived Barriers to a Pragmatic Treatment Trial in Rheumatoid Arthritis
Abstract Number: 1704

Identifying Primary Care Clinician Knowledge Gaps and Needs in Rheumatologic Care for Rural Veterans
Abstract Number: 1671

Identifying Rare Genetic Variants in Childhood-onset Monogenic Systemic Lupus Erythematosus
Abstract Number: 0162

Identifying Sleep Problems in Systemic Juvenile Idiopathic Arthritis (SJIA) Patients with Patient-reported Outcomes (PRO) Questionnaires
Abstract Number: 1176

Identifying Targets to Improve the Assessment of Psychosocial Risk Factors in Adolescent Patients: Perspectives from Pediatric Rheumatology Fellows in the United States and Canada
Abstract Number: 1332

Identifying the as Patient at Risk: Is Aortic Root Diameter Associated with HLA-B27?
Abstract Number: 0469

IFNγ Is Essential for Alveolar Macrophage Driven Lung Inflammation in Macrophage Activation Syndrome
Abstract Number: 1798

IgE Anti-dsDNA Antibodies in Systemic Lupus Erythematosus Are Associated with Higher Disease Activity at the Baseline and in Longterm Follow-up
Abstract Number: 1818

IgG and IgA Autoantibodies Against L1 ORF1p Expressed in Granulocytes Correlate with Granulocyte Consumption and Disease Activity in Pediatric Systemic Lupus Erythematosus
Abstract Number: 0416

IgG4-related Retroperitoneal Fibrosis. Retrospective Cohort
Abstract Number: 1911

IL-11 Expression in Systemic Sclerosis Pulmonary Fibroblasts Is Mediated by Caspase-1
Abstract Number: 1152

IL-18: A Biomarker That Reflects Disease Activity, Could It Be the Next Disease Activity Measure in Systemic Juvenile Idiopathic Arthritis?
Abstract Number: 1373

IL-23 Skin and Joint Profiling in Psoriatic Arthritis: Novel Perspectives in Understanding Clinical Responses to IL-23 Inhibitors
Abstract Number: 1107

IL1RN Polymorphism Predicts Weight Loss, Inflammatory Biomarker Changes and Knee Osteoarthritis Pain Relief After Bariatric Surgery
Abstract Number: 1570

Immune Checkpoint Inhibitor Treatment in Cancer: Immunomodulator Use and Evaluation by Rheumatology
Abstract Number: 1577

Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Impact on Function and Patient-Reported Quality of Life Measures Varies Depending on Pattern of Arthritis
Abstract Number: 1697

Immune Related Adverse Events from Checkpoint Inhibitor Therapy: Survey of Hospitalists’ Awareness and Experiences
Abstract Number: 1569

Immune Related Adverse Events Related to Check Point Inhibitors Among Outpatients in an Academic Center
Abstract Number: 1997

Immunogenicity of Adjuvanted Herpes Zoster Subunit Vaccine in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors and Controls: Preliminary Results
Abstract Number: 1619

Immunoglobulin G Subclass Ordering Patterns for IgG4-Related Disease at an Academic Medical Center
Abstract Number: 0639

Immunological Abnormalities in a SARS-CoV-2-Cytokine Release Syndrome Rheumatology Cohort
Abstract Number: 1097

Immunophenotypic Characterization of Myeloid Derived Supressor Cells (MDSCs) and Their Relationship to the Clinical Characteristics of Patients with Inflammatory Myopathies
Abstract Number: 0126

Immunophenotyping of Peripheral Blood Highlights an Association of Dysregulated Lymphocytes with Patients with Glucocorticoid-induced Osteonecrosis
Abstract Number: 1065

Immunostimulatory Herbal Supplement Use Is More Common Among Patients with Dermatomyositis
Abstract Number: 0598

Impact of a Dedicated Lupus Nephritis Clinic to Improve Time to Biopsy and Care Quality
Abstract Number: 0168

Impact of Adalimumab (Humira) Therapy on Ocular Inflammation, Selected Health Care Resource Utilization, and Patient-Reported Outcomes in Patients with Active Non-infectious Intermediate, Posterior, or Panuveitis in Routine Clinical Practice
Abstract Number: 1093

Impact of Blood Flow Restricted Strength Training on Myogenic Stem Cells and Myofiber Hypertrophy in Sporadic Inclusion Body Myositis Patients
Abstract Number: 1376

Impact of Body Composition Measures on the Response to Biological Disease-modifying Anti-rheumatic Drugs in Patients with Ankylosing Spondylitis
Abstract Number: 1207

Impact of Body Mass Index on Clinical Responses of Novel Subcutaneous Infliximab (CT-P13 SC) in Patients with Active Rheumatoid Arthritis: 1-Year Results from a Part 2 of Phase I/III Randomized Controlled Trial
Abstract Number: 0220

Impact of Concomitant Glucocorticoids on the Clinical Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: An Ad Hoc Analysis of Data from Three Phase 3 Studies
Abstract Number: 0614

Impact of COVID-19 Pandemic on the Rheumatology Practice in Mexico: Mexican College of Rheumatology Survey
Abstract Number: 0017

Impact of COVID19 on Missed/Cancelled Rheumatology Office Visits and Parenteral Immunosuppressive Medications
Abstract Number: 0609

Impact of Depressive Symptoms, Anti-depression Treatment on Direct Medical Costs Among Medicare Beneficiaries with Knee Osteoarthritis (KOA)
Abstract Number: 0902

Impact of Dose Escalation of Secukinumab in Patients with Psoriatic Arthritis in Real-World Setting
Abstract Number: 0911

Impact of Filgotinib on Structural Lesions in the Sacroiliac Joints at 12 Weeks in Patients with Active Ankylosing Spondylitis: Correlation with Clinical Endpoints
Abstract Number: 0268

Impact of Flares on Healthcare Resource Usage and PROs in Systemic Lupus Erythematosus Patients
Abstract Number: 0885

Impact of HLA-B27 Status on Clinical Outcomes in Patients with Ankylosing Spondylitis Treated with Secukinumab
Abstract Number: 0847

Impact of Hydroxychloroquine Treatment on Immunologic Markers in SLE Depends on Ethnicity
Abstract Number: 1367

Impact of Ixekizumab on Work Productivity in Non-Radiographic Axial Spondyloarthritis Patients: Results from the COAST-X Trial at 52 Weeks
Abstract Number: 0868

Impact of Proteinuria on the Clearance of Monoclonal Antibodies: Potential Clinical Implications
Abstract Number: 1272

Impact of Remission and Low Disease Activity Status on Hospitalizations Among SLE Patients from the GLADEL Latin American Cohort
Abstract Number: 0992

Impact of Selective Inhibitors of Nuclear Export on SLE Plasma Cells Is Modulated by the BM Microenvironment
Abstract Number: 0873

Impact of Skin Involvement on Disease Burden Among Patients with Psoriatic Arthritis: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Abstract Number: 0480

Impact of Targeting Remission or Low Disease Activity on 10-year Severity in Rheumatoid Arthritis : Data from ESPOIR Cohort
Abstract Number: 1583

Impact of Telehealth Implementation on Practice Patterns and Electronic Health Record Utilization During COVID19
Abstract Number: 1685

Impact of the COVID-19 Pandemic Among Children with Rheumatic Diseases from Around the Globe
Abstract Number: 0443

Impact of the COVID-19 Pandemic on Racial and Ethnic Minority Groups Diagnosed with Rheumatic Diseases
Abstract Number: 1804

Impact of the Kynurenine/Tryptophan Pathway on Cognitive Dysfunction and Depression in Systemic Lupus Erythematosus
Abstract Number: 1568

Impact of the SARS-CoV-2 Pandemic on a Cohort of Patients with Rheumatic Complications of Immune Checkpoint Inhibitors: A Registry Survey Study
Abstract Number: 1717

Impact of Treatments on Favorable Outcome over the First 10 Years of Disease in Early Rheumatoid Arthritis: Results from a WCE Model in the ESPOIR Cohort
Abstract Number: 1718

Impact of Treatments on Radiographic Progression over the First 10 Years of Disease in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort
Abstract Number: 0896

Impact of Upadacitinib on Reducing Pain in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Trials in Patients with Inadequate Response to Non-biologic or Biologic DMARDs
Abstract Number: 0228

Impact of Upadacitinib or Adalimumab as Initial Therapy on the Achievement of 48-Week Treatment Goals in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: Post Hoc Analysis of a Phase 3 Study
Abstract Number: 1891

Impact of Utilising Smart Phone Application in Ankylosing Spondylitis: SMART- as Study
Abstract Number: PP01

Impacting Change Through Facilitation and Advocacy for Lupus
Abstract Number: 1151

Implementation and Initial Experience with a Screening Protocol for Inflammatory Hyperferritinemia
Abstract Number: 1712

Implementation of a Musculoskeletal Ultrasound (MSUS) Curriculum in an Academic Rheumatology Fellowship Within an Integrated Health System: A Four-Year Experience
Abstract Number: 1142

Implementation of an Evidence-based Transition Clinic in a Pediatric Rheumatology Academic Institution
Abstract Number: 1145

Implementation of Web-Based Patient-Reported Outcome Measures (PROMs) in SLE Clinical Care: A Multi-Center Prospective Cohort Study
Abstract Number: 1461

Implementation, Feasibility and Acceptability of Take Charge, an Email Series to Increase Knowledge of Lupus Self-Management Skills
Abstract Number: 1371

Improvement in Patient-Reported Outcomes for Upadacitinib versus Placebo Among Patients with Psoriatic Arthritis and an Inadequate Response to Biologic Disease-Modifying Anti-Rheumatic Drugs
Abstract Number: 1341

Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis with Inadequate Response to Non-Biologic DMARDs Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Study
Abstract Number: 0877

Improvements in Global Functioning and Health-related Quality of Life and Their Association with Disease Activity and Functional Improvement in Patients with Active Ankylosing Spondylitis Treated with Upadacitinib
Abstract Number: 1587

Improving Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus in an Internal Medicine Resident Clinic: A Quality Improvement Initiative
Abstract Number: 0571

Improving Care for Patients with Inflammatory Arthritis by Enabling Physical Therapists to Directly Refer to Rheumatologists: A Qualitative Study
Abstract Number: PP07

Improving Communication with My Physician Drastically Improved My Health
Abstract Number: 1592

Improving Documentation of Smoking Cessation Counseling Among Spondyloarthropathy Smokers
Abstract Number: 1124

Improving Documentation Rates of Non-Pharmacologic Therapies for Knee Osteoarthritis
Abstract Number: 0113

Improving Glucocorticoid-Induced Osteoporosis Screening and Management in Patients with Rheumatic Diseases Using the 2017 ACR Guidelines
Abstract Number: 0115

Improving Osteoporosis Screening in Men at a Resident-run Primary Care Clinic: A Quality Improvement Project
Abstract Number: 1624

Improving Pneumococcal Vaccination in Veterans with Rheumatic Diseases
Abstract Number: 1623

Improving Pneumococcal Vaccination Rates Among Immunosuppressed Adults in an Academic Rheumatology Clinic Utilizing a Nurse Driven Protocol
Abstract Number: 0457

Improving Pneumococcal Vaccination Rates in Immunosuppressed Rheumatology Patients
Abstract Number: 1778

Improving Teratogenic Medication Consent and Sexual Activity Screening in Adolescent and Young Females: A Pediatric Rheumatology Reproductive Health Initiative
Abstract Number: 1613

Improving Transition Policy Dissemination and Care Team Communication in Pediatric Rheumatology Clinic Through Standardization of Workflow and Electronic Health Record Documentation
Abstract Number: 1966

Improving Value Concordant Care Through Increased Use of Subcutaneous Methotrexate in Rheumatoid Arthritis
Abstract Number: 1184

In a Prospective RA Cohort, Higher Baseline Disease Activity Is an Independent Predictor of Decline in Left Ventricular Diastolic Function
Abstract Number: 1917

In Myositis Patients, Sjögren’s Syndrome Is Associated with Inclusion Body Myositis and with anti-cN1A Antibody Independently of the Myositis Subgroups
Abstract Number: 1940

In Newly Diagnosed Giant Cell Arteritis in a Real Life Setting Relapses Are Seen in More Than a Third of Patients – and Despite Faster Early Reduction High Cumulative Glucocorticoid Doses Are Reached
Abstract Number: 0940

In Patients with Inflammatory Arthritides Central Pain Sensitization Is Strictly Associated with Functional Disability
Abstract Number: 1881

In Radiographic Axial Spondyloarthritis, Bridging Syndesmophytes Increase Risk of Facet Joint Ankylosis Development on the Same Vertebral Level While Facet Joint Ankylosis Does Not Increase Risk of Same Level Syndesmophytes Development
Abstract Number: 0565

In Those with Unilateral Frequent Knee Pain, Between-Limb Differences in Stance Time During Walking Increase the Risk of Frequent Pain in the Other Knee: The MOST Study
Abstract Number: 0347

In Two Phase-3 Trials, Guselkumab Reduced Fatigue over 52 Weeks in Patients with Psoriatic Arthritis and Demonstrated Independent Treatment Effects on Fatigue After Adjustment for Clinical Response (ACR20)
Abstract Number: 0450

In Vitro Characterization of Inflammatory Arthritis Associated with Immune Check Point Inhibition
Abstract Number: 1705

In-Person Musculoskeletal Exam Demonstration by Rheumatologist More Effective Than Virtual PowerPoint Presentation in Teaching Internal Medicine Residents
Abstract Number: 0898

Inadequate Response Among Psoriatic Arthritis Patients Prescribed Advanced Therapy in a Real-world US Commercially Insured Population
Abstract Number: 0564

Incidence and Progression of Foot Osteoarthritis
Abstract Number: 2002

Incidence and Risk Factors for Herpes Zoster in Rheumatoid Arthritis Patients Receiving Upadacitinib
Abstract Number: 0215

Incidence and Risk of Venous Thromboembolic Events Among Patients with Rheumatoid Arthritis Enrolled in the Upadacitinib Clinical Trial Program
Abstract Number: 0277

Incidence and Time to Classification of Systemic Lupus Erythematosus by Three Different Classification Criteria
Abstract Number: 0467

Incidence of COVID-19 in Patients Treated with Infliximab Compared to Patients Treated with Rituximab
Abstract Number: 0488

Incidence of Dementia in Patients with Rheumatoid Arthritis and Association with DMARDs – Analysis of a National Claims Database
Abstract Number: 0548

Incidence of First Cardiovascular Event in Spanish Patients with Chronic Inflammatory Rheumatic Diseases. Prospective Data After Five Years of Follow Up
Abstract Number: 0114

Incidence of Follow-Up Dual-Energy X-Ray Absorptiometry Scanner Error: A Contributor to Precision Error
Abstract Number: 0183

Incidence of Malignancies in Japanese Patients with Rheumatoid Arthritis: Data from a Large Japanese National Registry
Abstract Number: 1436

Incidence Rate, Predictors and Outcome of Stroke in Patients with ANCA Associated Vasculitis – A Population-based Study
Abstract Number: 1684

Increase in Emergency Department Visits and Hospitalizations, Decrease in Outpatient Visits Following Transition to Adult Rheumatologic Care
Abstract Number: 0554

Increased Burden of Painful Arthritis and Rheumatism Following the Chikungunya Epidemic 2006: India Rural Population Survey 2018
Abstract Number: 0191

Increased Frequency of Lower Limb Arterial Obstruction in Rheumatoid Arthritis
Abstract Number: 1182

Increased Prevalence of Carotid Atherosclerosis in Postmenopausal Women with Rheumatoid Arthritis: A Case Control Study
Abstract Number: 1858

Increased Proportion of TH17, TH22 and TC17 Cells and the Correlation to IL-22 and Clinical Parameters in Patients with Ankylosing Spondylitis from Northern Sweden
Abstract Number: 0382

Increased Rates of Obstetric Complications Prior to Systemic Sclerosis Diagnosis
Abstract Number: 0756

Increased Risk of Hospitalization in Patients with RA Who Are ACPA Positive and Shared Epitope Positive
Abstract Number: 0338

Increased Risk of Lymphoproliferative Disorders in Psoriatic Arthritis
Abstract Number: 1220

Increased Serum Levels of Circulating Vimentin and Citrullinated Vimentin Are Differently Regulated by Tocilizumab and Methotrexate Monotherapies in Rheumatoid Arthritis
Abstract Number: 0057

Increased Susceptibility to Measles in Patients from Central America and Mexico in a U.S. Rheumatology Clinic
Abstract Number: 1721

Increasing Autoantibody Positivity During Pre-RA Is Associated with the Imminent Development of Classifiable RA
Abstract Number: 0478

Increasing Awareness of Advocacy During Early Career – a Web-Based Educational Program
Abstract Number: 0604

Increasing the Rate of Pneumococcal Vaccination in an Academic Rheumatology Outpatient Clinic
Abstract Number: 0887

Increasing Use of Biologics in Treatment of Systemic Lupus Erythematosus Patients in US Clinical Practice: Real-World Observations from Trio Health and the American Rheumatology Network
Abstract Number: 0118

Indicators of Effectiveness After 6 Years of Follow-up in a Fracture Liaison Service
Abstract Number: 2003

Individualized Prediction of Response to Methotrexate Treatment in Patients with Rheumatoid Arthritis: A Pharmacogenomics-driven Machine Learning Approach
Abstract Number: 1010

Infection and Malignancy Outcomes in Patients with RA Treated with Abatacept: Results from a Multinational Surveillance Study
Abstract Number: 0622

Infection-induced MPO-ANCA Associated Vasculitis: A Systematic Review of Published Case Reports
Abstract Number: 0697

Inferior Tendon Structure and Function Seen in Patients with Achilles Tendinopathy and Neovascularization of the Achilles Tendon
Abstract Number: 0406

Infliximab in Refractory Uveitis Due to Behçet’s Disease: Long Term Follow-up and Therapy Optimization. Multicenter Study of 103 Caucasian Patients
Abstract Number: 0192

Influence of Inflammatory and Non-inflammatory Rheumatic Disorders on the Clinical and Biological Profile of Adult-onset Diabetes
Abstract Number: L04

Influenza Adverse Events in Patients with Rheumatoid Arthritis in the Tofacitinib Clinical Program
Abstract Number: 0634

Influenza Knowledge and Barriers to Vaccination in Immunosuppressed Patients in the Pediatric Rheumatology Clinic
Abstract Number: 0815

Initial Pharmaceutical Management in a National Cohort of Elderly-Onset Rheumatoid Arthritis Patients
Abstract Number: 1843

Integrated Efficacy of the AURORA 1 and AURA-LV Trials Confirms Voclosporin Rapid Proteinurea Reduction in the Presence of Low-Dose Steroids
Abstract Number: 1910

Integrated Molecular Analysis of Systemic Sclerosis Skin and Blood Highlights Significant Differences Between Major Autoantibody Subgroups
Abstract Number: 0229

Integrated Safety of Filgotinib in Patients with Moderately or Severely Active Rheumatoid Arthritis Receiving Treatment for up to 5.5 Years
Abstract Number: 0437

Integrating Reproductive Health in Systemic Lupus Erythematosus in a Tertiary Care Setting
Abstract Number: 0502

Integration of Clinical and Protein Markers Through Machine Learning to Distinguish Patients with Psoriasis Arthritis from Those with Psoriasis Without Psoriatic Arthritis
Abstract Number: 1450

Integrative Analysis of DNA Methylation and Gene Expression in Monocytes from Primary Antiphospholipid Syndrome Patients Identifies a Gene Expression Signature Associated with Their Atherothrombotic Phenotype
Abstract Number: 1462

Intensity and Duration of Silica Exposure Increase Rheumatoid Arthritis Risk Among Coal Miners
Abstract Number: 0990

Interferon Lambda Promotes Human Plasma Cell Differentiation in Lupus and Healthy Donors
Abstract Number: 0171

Interferon Response Gene Expression Differs in Whole Blood, Peripheral Blood Mononuclear Cells, Monocytes, T Cells, B Cells, and NK Cells in Patients with the Autoinflammatory Interferonopathies, CANDLE and SAVI
Abstract Number: 1525

Intergenic HLA Variants in African American Patients with Systemic Sclerosis Regulate Expression of HLA-DRB1
Abstract Number: 0099

Interleukin 6 Concentration in Synovial Fluid of Patients with Different Types of Arthritis
Abstract Number: 0335

Interleukin-17 Blockade Leads to Shifts from Stage-based Towards Response-based Disease Clusters- Comparative Data from Very Early and Established Psoriatic Arthritis
Abstract Number: 1519

Interleukin-17D, a Cytokine Derived from Stromal Cells, Attenuates Joint Inflammation
Abstract Number: 0497

Interleukin-23 Acts Directly on Podocytes and Contributes to the Development of Glomerulonephritis
Abstract Number: 1089

Intermuscular Adipose Tissue in Patients with Systemic Lupus Erythematosus
Abstract Number: 0829

International Comparison of Japanese and US Cross Country Utilization of RA Medications
Abstract Number: 1431

Interstitial Lung Disease in Patients with ANCA Associated Vasculitis – a Prospective Single Centre Study
Abstract Number: 1524

Interstitial Lung Disease, Kidney Inflammation and Myositis Are Induced by Transfer of PBMC Derived from Systemic Sclerosis Patients into Rag2-/-/ IL2rg-/- mice
Abstract Number: 0591

Intervention to Improve SLE Medication Adherence Using Surescripts Pharmacy Refill Data
Abstract Number: 1852

Intestinal Permeability in the Adjuvant Induced Arthritis Model: Preliminary Study and Impact of NSAIDs
Abstract Number: 1111

Intra-Articular Mineralization on Knee CT Increases Risk of Knee Pain: The Multicenter Osteoarthritis Study
Abstract Number: 1795

Intracellular Homocysteine and Homocysteine Metabolites in Systemic Lupus Erythematosus (SLE)
Abstract Number: 1113

Intrameniscal Signal Alterations Strongly Predict Destabilizing Meniscal Tears and Accelerated Knee Osteoarthritis: Data from the Osteoarthritis Initiative
Abstract Number: 0969

Investigating Murine Joint-Draining Lymphatics: Lineage Tracing and Single Cell RNA Sequencing Reveal Evidence That Popliteal Lymphatic Muscle Cells and Their Progenitors Represent Distinct Cell Types Divergent from Striated and Vascular Muscle Cells
Abstract Number: 1404

Investigating the Dermatomyositis Skin Inflammatory Infiltrate Using Image Mass Cytometry
Abstract Number: 0296

Investigating the Differences in ANA Specificities Between Asymptomatic and Symptomatic ANA+ Individuals
Abstract Number: 1913

Investigation of the Cellular Mechanism for Estradiol-Induced Dermal Fibrosis
Abstract Number: 1222

Iron Management in Patients with Rheumatoid Arthritis
Abstract Number: 0834

Is Disease Severity Greater Among Patients with Rheumatoid Arthritis Who Receive a Newly Approved Biologic? Real-world US Experience with Sarilumab from the ACR RISE Registry
Abstract Number: 0574

Is Hydroxychloroquine Use a Proxy for Health Care Access? Predictors of First Dispensing Among Medicaid Beneficiaries with Incident Lupus
Abstract Number: 0893

Is It Feasible to Achieve Recommended Therapeutic Target Objective in Patients with Axial Spondyloarthritis in Clinical Practice? Data from the SpA-paz Cohort
Abstract Number: 0219

Is It Realistic to Stop Prednisone in Early Rheumatoid Arthritis? A Subanalysis from the BeSt and IMPROVED Studies
Abstract Number: 0964

Is Meniscal Status in the Anterior Cruciate Ligament Injured Knee Associated with Change in Bone Surface Area? An Exploratory Analysis of Data from the KANON Trial
Abstract Number: 0339

Is Sex-adjusted Treatment in Early-PsA Justified?
Abstract Number: 1305

Is the Occurrence of Acute Anterior Uveitis Linked Primarily to Ankylosing Spondylitis (AS) or to HLA-B27? Results of a 35-Year Follow-Up Family Study of a Swiss Cohort of Patients with AS
Abstract Number: 0404

Isolated Aortitis: Single Centre Experience of Clinical Spectrum and Management
Abstract Number: 0747

Isotope-Labeling-LC-MS-based Metabolic Profiling of Multiple Serum Sample Sets for the Discovery of High-confidence Rheumatoid Arthritis Biomarkers
Abstract Number: 0378

Itch as the Major Mediator of the Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis
Abstract Number: 1708

Itching to Learn: Infusion Reactions Curriculum for Medicine Trainees
Abstract Number: 0880

Ixekizumab Improves Signs and Symptoms of Patients with Radiographic and Non-radiographic Axial Spondyloarthritis and Extra-articular Manifestation of Enthesitis Through 16 Weeks
Abstract Number: 0890

Ixekizumab Treatment Improves Fatigue, Spinal Pain, Stiffness, and Sleep in Patients with Nonradiographic Axial Spondyloarthritis